February 2012
- Gene microarray technology yields interesting results in the laboratory
- Novel KIT inhibitor also targets a new suspect; clinical trials to begin this year
- Simple two-gene test sorts out similar gastrointestinal cancers
- 'Treatment, trials and trails, oh my' but life must go on
- John Leary, a wonderful father, husband, friend and student
- April 2007 clinical trial update
April 2007
- Gene microarray technology yields interesting results in the laboratory by Matt van de Rijn, M.D. In this issue of the newsletter I would like to describe the type of experiments we perform in my laboratory.
- Novel KIT inhibitor also targets a new suspect; clinical trials to begin this year by Jerry Call Researchers, led by Daruka Mahadevan M.D., Ph.D., at the University of Arizona in Tucson, have characterized a novel mechanism of resistance to Gleevec that may be present in some GIST patients.
- Simple two-gene test sorts out similar gastrointestinal cancers "A powerful two-gene test distinguishes between a pair of nearly identical gastrointestinal cancers that require radically different courses of treatment," researchers report this week in the online Early Edition of the Proceedings of the National Academy of Sciences.
- 'Treatment, trials and trails, oh my' but life must go on by Mark Becker Occasionally I have read that some survivor says that getting cancer was the best thing that ever happened to him. I think, “That person is insane.”
- John Leary, a wonderful father, husband, friend and student John Leary was a man committed to living his life. No matter what he chose to do, he did it his own way. Because of this, he had the respect of everyone around him.
- April 2007 clinical trial update by Jim Hughes